BioTech IP Review

Journal: Cell (Volume 176, Issue 3, 2019)
Authors: Pasolli, Asnicar, Manara, Zolfo, and colleagues
Key Topic: Human microbiome diversity and metagenomic reconstruction

---

What This Paper is About

This study used large‑scale metagenomic sequencing to reconstruct 154,723 microbial genomes from more than 9,000 metagenomic samples collected across diverse human populations — spanning different ages, geographic regions, and lifestyles. The dataset included both previously known and unknown species of microbes that inhabit human body sites such as the gut and mouth.

Key findings include:

• The reconstruction of tens of thousands of previously uncharacterized microbial genomes, greatly expanding the human microbiome’s known diversity.
• Identification of microbes that were absent from existing reference collections, showing that a large fraction of human‑associated microbes had not been isolated or sequenced before.
• Creation of a reference catalog that increases the mappability of metagenomic sequencing reads, improving researchers’ ability to link microbial genes with functions and health traits.

---

Why It’s Important

This paper is significant because it:

1. Vastly Expands the Microbiome Reference Universe

By reconstructing over 150,000 genomes — nearly half of which were previously unknown — researchers now have a much broader view of the microbial species associated with humans. This enhances studies of how microbes influence health, disease, nutrition, immunity, and drug responses.

2. Enables Better Analysis and Diagnostics

With a richer genome catalog, scientists can more accurately interpret metagenomic sequencing data, identify organism‑specific biomarkers, and link microbial functions to clinical conditions (e.g., inflammatory bowel disease, obesity, cancer).

3. Supports Development of Microbiome‑Based Therapies

Understanding the diversity and functional potential of the human microbiome is foundational for future microbiome therapeutics — such as engineered probiotics, microbial enzyme therapies, and microbiome modulation interventions.

---

Summary

This Cell paper dramatically expanded the catalog of known human‑associated microbes using high‑throughput sequencing and computational assembly, showing that the human microbiome is much more diverse than previously appreciated. It provides a resource that underpins future biomedical research, diagnostics, and therapeutic development tied to human–microbe interactions.